NCT02737072 2019-08-12A Study of LY2510924 and Durvalumab in Participants With Solid TumorsEli Lilly and CompanyPhase 1 Terminated9 enrolled 13 charts
NCT01391130 2019-07-23A Study of LY2510924 and Sunitinib in Patients With Metastatic Renal Cell CarcinomaEli Lilly and CompanyPhase 2 Terminated110 enrolled 14 charts
NCT01439568 2019-07-23A Study of LY2510924 in Participants With Extensive-Stage Small Cell Lung CarcinomaEli Lilly and CompanyPhase 2 Completed90 enrolled 13 charts